# A conserved salt bridge network stabilizes the hepatic organic anion transporters OATP1B1 and OATP1B3

**Authors:** Drew Barber, Fiona Naughton, Niek van Hilten, Michael Grabe, Aviv Paz

PMC · DOI: 10.1016/j.jbc.2026.111217 · The Journal of Biological Chemistry · 2026-01-28

## TL;DR

This study identifies a salt bridge network that stabilizes liver transporters OATP1B1 and OATP1B3, influencing their function and conformational changes.

## Contribution

The discovery of a conserved salt bridge network centered around E185 that stabilizes the structure and function of OATP1B1 and OATP1B3.

## Key findings

- A salt bridge network centered around E185 is crucial for the uptake activities of OATP1B1 and OATP1B3.
- The salt bridge network stabilizes the inward cavity and connects the N- and C-bundles of the proteins.
- The network changes with conformation and does not involve ligand coordination.

## Abstract

The organic anion transporting polypeptide (OATP)-1B1 and -1B3 are liver-specific transporters that govern the uptake of numerous endogenous molecules and drugs before their metabolism and excretion by the hepatocytes. Structurally, these two transporters are members of the major facilitator superfamily, operating by the alternating access mechanism that facilitates the movement of solutes between extracellular and intracellular compartments. Given their dynamic nature, salt bridges often modulate the conformations of transporters and participate in the orchestration of conformational changes. In this study, we identified and characterized a network of salt bridges within the internal cavities of OATP1B1 and OATP1B3 by cell-based uptake assays, uptake kinetics, and molecular dynamics simulations. These experiments revealed that a salt bridge network centered around E185 is crucial for uptake activities in these two proteins, as it stabilizes the inward cavity of the proteins and bridges the N- and C- bundles of the protein. Interestingly, this salt bridge network changes as a function of conformation. Furthermore, the residues studied do not participate in ligand coordination in the published structures nor in our simulations. These findings advance our understanding of the elaborate network of ionic interactions that govern the structure and dynamics of OATP1B1, OATP1B3, and other MFS transporters.

## Linked entities

- **Proteins:** SLCO1B1 (solute carrier organic anion transporter family member 1B1), SLCO1B3 (solute carrier organic anion transporter family member 1B3)

## Full-text entities

- **Genes:** PCSK1 (proprotein convertase subtilisin/kexin type 1) [NCBI Gene 5122] {aka BMIQ12, NEC1, PC1, PC1/3, PC3, SPC3}, TXK (TXK tyrosine kinase) [NCBI Gene 7294] {aka BTKL, PSCTK5, PTK4, RLK, TKL}, SLCO1B1 (solute carrier organic anion transporter family member 1B1) [NCBI Gene 10599] {aka HBLRR, LST-1, OATP-C, OATP1B1, OATP2, OATPC}, SLCO1B3 (solute carrier organic anion transporter family member 1B3) [NCBI Gene 28234] {aka HBLRR, LST-2, LST-3TM13, LST3, OATP-8, OATP1B3}, CBX4 (chromobox 4) [NCBI Gene 8535] {aka NBP16, PC2}, SLC22A1 (solute carrier family 22 member 1) [NCBI Gene 6580] {aka HOCT1, OCT1, oct1_cds}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, SLCO1A2 (solute carrier organic anion transporter family member 1A2) [NCBI Gene 6579] {aka OATP, OATP-A, OATP1A2, SLC21A3}, OATP1 (ornithine aminotransferase pseudogene 1) [NCBI Gene 4945] {aka OATL3}
- **Diseases:** breast and prostate cancer (MESH:D001943), colon, prostate, pancreatic adenocarcinomas (MESH:D003110), PC (MESH:C566443), MFS (MESH:D004830), cancer (MESH:D009369)
- **Chemicals:** 2',7'-dichlorofluorescein (MESH:C037631), taurocholate (MESH:D013656), agarose (MESH:D012685), lipid (MESH:D008055), CO2 (MESH:D002245), methotrexate (MESH:D008727), Waters (MESH:D014867), glycine (MESH:D005998), NaOH (MESH:D012972), docetaxel (MESH:D000077143), Hydrogens (MESH:D006859), glutamate (MESH:D018698), DTT (MESH:D004229), Laemmli buffer (MESH:C088816), O (MESH:D010100), Hepes (MESH:D006531), disulfide (MESH:D004220), doxorubicin (MESH:D004317), Salt (MESH:D012492), NaCl (MESH:D012965), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (MESH:C028694), 17beta-estradiol 17-glucosiuronic acid (-), carbon (MESH:D002244), pravastatin (MESH:D017035), alanine (MESH:D000409), estrone 3-sulfate (MESH:C017296), bicarbonate (MESH:D001639), bromsulphthalein (MESH:D013448), paclitaxel (MESH:D017239), polyethylenimine (MESH:D011094), irinotecan (MESH:D000077146), N (MESH:D009584), 4',5'-dibromofluorescein (MESH:C523249), n-Dodecyl-beta-D-Maltoside (MESH:C040358), lactose (MESH:D007785)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** glycine for 10, L545S, R580A, F244A, F386V, K41A, L545, R181, H54Q, W259A, E172D, F352, C with 1, K41E, R181A, N-to-C, Y352F, E185Q
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12955633/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12955633/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12955633/full.md

---
Source: https://tomesphere.com/paper/PMC12955633